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APPLICATION OF A FAST-TRACK SURGERY PROTOCOL FOR VIDEO-ASSISTED 
THORACOSCOPIC THYMECTOMY IN NON-THYMOMATOUS MYASTHENIA 
GRAVIS: A CASE-CONTROL STUDY 
Dazhi Pang, J. Li, Q. Luo, Y. Lihua, A. Sihoe 
 
Department of Surgery, University of Hong Kong Shenzhen Hospital, Shenzhen, China 
 
OBJECTIVES: The use of fast-track surgery (FTS) management has rarely been assessed in the 
treatment of non-thymomatous myasthenia gravis (NTMG) using video-assisted thoracic surgery 
(VATS). METHODS: FTS management was applied in 68 consecutive patients receiving VATS 
thymectomy for NTMG. Our FTS protocol included: maintenance of each patient’s original anti-
cholinesterase and steroid therapy perioperatively; no plasmapharesis or immunoglobulin therapy 
preoperatively; avoidance or minimization of central lines, chest tubes and ICU stays 
postoperatively; and specific management of postop respiratory difficulties without ‘knee-jerk’ 
assumption of myasthenic crisis. These patients were matched for multiple demographic and 
clinical variables with 68 similar patients from a historical cohort (VATS for NTMG but no FTS 
management) and clinical outcomes were compared. RESULTS: Complications occurred in 9 
patients (13.2%) in the FTS and 13 patients (19.1%) in the Control groups (P = 0.35). Specifically, 
9 patients (13.2%) in the FTS group and 8 patients (11.7%) in the Control group (P = 0.79) 
experienced respiratory difficulties in the postop period. In the 9 FTS patients, the cause of the 
dyspnoea was found to be sputum retention and the patients responded to clearance of the sputum 
plus muscarinic cholinoreceptor agonist therapy. In none of these patient did myasthenic crisis 
develop, or was ICU readmission or ventilatory support required.The mean initial postoperative 
ICU stay durations in the FTS and Control groups were 1.6 ± 2.1 h vs 37.1 ± 16.3 h respectively 
(P = 1.3E-17). The mean chest tube durations were 0.7 ± 1.3 h vs 31.1 ± 16.3 h respectively (P = 
6.3E-34). The mean postoperative lengths of stay were 3.5 ± 0.8 days vs 7.6 ± 1.7 days 
respectively (P = 2.9E-19). The mean total expenses of the hospital stay were US$ 2263.1 ± 301.3 
vs US$ 5116.3 ± 2585.1 respectively (P = 2.1E-13). CONCLUSIONS: Use of an FTS protocol 
after VATS for NTMG is safe and may complement VATS in expediting patient recovery. 
Sputum retention should be carefully distinguished from myasthenic crisis after surgery, and 
treated accordingly. 
